CAP® technology – a fully developed expression system based on human cells (amniocytes)

  • Fully documented and certified Master Cell Bank according to ICH guidelines and European Pharmacopoiea
  • Biologics Master File for CAP Technology submitted to U.S. FDA

CAP-Go is a platform of individual glyco-optimized cell lines for tailor-made production of recombinant proteins previously out of reach

CAP-GT is a platform for industrial scale production of Lentiviral, Adenoviral and AAV gene therapy vectors